H.I.G. Capital has successfully sold its portfolio company Soleo Health to Court Square Capital and WindRose Health Investors, positioning the company for continued growth in the specialty pharmacy and infusion services market.

Information on the Target

Soleo Health, headquartered in Frisco, TX, is a leading omnichannel infusion platform dedicated to providing personalized healthcare solutions for patients suffering from complex, rare, and ultra-rare medical conditions. The company operates a robust network of 26 pharmacies and over 30 ambulatory infusion suites strategically located across the United States, establishing a comprehensive healthcare service reach. Soleo Health's extensive pharmacy licensure, coupled with a specialized nursing network, enables the company to serve patients in all 50 states efficiently.

Under the stewardship of H.I.G. Capital, Soleo Health has evolved significantly into an industry leader within the specialty pharmacy and infusion market. The firm has facilitated major growth initiatives, such as expanding Soleo's footprint through new pharmacy locations and infusion suites, implementing a differentiated clinical model tailored to specific therapies, and diversifying its offerings in payor, site-of-care, and treatment options. These strategic enhancements have solidified Soleo's position in the competitive health services landscape.

Industry Overview in the U.S.

The U.S. healthcare industry, particularly the specialty pharmacy and infusion sector, is characterized by rapid growth and increasing demand for personalized care solutions. With advancements in medical technology and treatment options for complex conditions, there